Table 3 Neuromuscular blockade (NMB) monitoring and the use of NMB antagonists
Intra-operative NMB monitoring (n = 63) | No intra-operative NMB monitoring (n = 177) | P value | |||
|---|---|---|---|---|---|
TOFR > 0.9 | RNMB | TOFR > 0.9 | RNMB | ||
Non-reversed (n = 165) | 11/12 | 1/12 | 101/153 | 52/153 | 0.106# |
Neostigmine (n = 14) | 9/9 | 0/9 | 3/5 | 2/5 | 0.11# |
Sugammadex (n = 61) | 42/42 | 0/42 | 16/19 | 3/19 | 0.028# |